Powered by

Syros Pharmaceuticals Launches with $30 Million Series A Financing

Apr 11, 2013 - Business Wire
Board and Executive Moves-Mergers and Acquisitions

Syros Pharmaceuticals , a newly launched company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases, today announced that it has completed a $30 million Series A financing led by company Co-founders ARCH Venture Partners and Flagship Ventures . Syros will use the capital to accelerate the discovery and development of novel gene control medicines. The journal Cell today published two manuscripts1from Syros Scientific Co-founders based upon the dis...